Navigation Links
Alzheimer's Patients May Suffer 'Silent' Seizures
Date:9/5/2007

Mice with similar ailment experienced these subtle attacks, scientists say

WEDNESDAY, Sept. 5 (HealthDay News) -- Scientists say mice genetically altered to develop an Alzheimer's-like illness undergo "silent" brain seizures.

According to researchers at the Baylor College of Medicine, the seizures may explain why some people with advanced Alzheimer's have "spells" of increased confusion. The seizures observed in the mice would not be recognizable in the same way a convulsion or epileptic seizure can be noticed.

These subtle seizures may be linked to cellular changes caused by high brain levels of the Alzheimer's-linked amyloid beta protein.

Understanding the process behind the seizures may lead to treatments that can prevent or even reverse the progression of the disease, the researchers said in the September issue of Neuron.

The research team recorded electrical brain waves in the hippocampus, deep in the mice's brains. The hippocampus is a brain area associated with memory.

"This discovery has helped identify a new and potentially reversible neural mechanism that can explain the episodes of sudden severe confusion found in cases of advanced Alzheimer's disease," Dr. Jeffrey Noebels, director of the Bluebird Circle Developmental Neurogenetics Laboratory at Baylor College of Medicine, said in a prepared statement. "The cellular changes that give rise to this hyperexcitability appear slowly as the disease progresses, and, at a certain point, the brain networks actually become hyperexcitable, despite the loss of synapses and brain cells in this brain region. Further study may point to early treatment that might prevent these electrical brain spells, as well as slow down the progression of this debilitating disease."

Prior to this research, spells of increased confusion were thought to be a result of degenerating nerve cells. According to the researchers, the study indicated that they may result from excess amyloid beta and could signal future cognitive failure. Amyloid beta is a toxic protein fragment found in the brains of people with Alzheimer's disease and similar disorders.

Alzheimer's disease is the most common form of dementia. More than 5 million Americans are living with the disease, which is characterized by a progressive loss of memory and cognitive function. There is no known cure for the disease.

More information

For more about Alzheimer's disease, visit the Alzheimer's Association.



-- Madeline Vann



SOURCE: Baylor College of Medicine, news release, Sept. 5, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Testing genes for disease does not cause harm to children of people with Alzheimers
2. Age-Dependent Alterations Not Specific For Alzheimers Disease
3. Killing two birds (cholesterol and Alzheimers disease) with the same stone
4. Cancer Causing Protein May Heal Alzheimers
5. Exposure To High Aluminum Levels In Tap Water Lead To Rare Form Of Alzheimers
6. Sugar variant may make a world of difference to Alzheimers disease
7. Alzheimers Disease Enzyme may Interfere With Brain Function
8. Emotional Stress Could Be a Factor in Causing Alzheimers: Study
9. Alzheimers Incidence is Set to Quadruple by 2050
10. GAB2-A New Alzheimers Gene Identified
11. Reduced Oxygen to the Brain Increases Alzheimers Risk in Stroke Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of Family Medicine's ... President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. ... 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming the role ...
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
Breaking Medicine Technology: